Relationship between hemolysis and lipid oxidation in red blood cell-spiked fish muscle; dependance on pH and blood plasmaShow others and affiliations
2024 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 14, no 1, article id 1943Article in journal (Refereed) Published
Abstract [en]
The relationship between hemolysis and lipid oxidation was explored in red blood cell (RBCs)-spiked washed cod mince (WCM). At pH 6.8 and 3 ± 1 °C, intact RBCs (71 µM Hb) delayed lipid oxidation by 1 day compared to WCM with partly or fully lysed RBCs which oxidized immediately. Intact RBCs also lowered peak peroxide value (PV) and thiobarbituric acid reactive substances (TBARS) with up to 59.5% and 48.1%, respectively. Adding 3% (v/w) blood plasma to RBC-spiked WCM delayed the lipid oxidation onset from 1 to 3–4 days without delaying hemolysis. At pH 6.4 the oxidation onset in RBC-WCM was the same as for pH 6.8 while at pH 7.2–7.6 lipid oxidation was suppressed for 7 days. Micrographs revealed RBC-lysis from day 2 at pH 6.4 but at pH 7.6, RBC stayed intact for ≥ 7 days. Thus, assuring presence of plasma-derived antioxidants and/or elevating muscle pH to avoid hemolysis can aid valorization of blood rich underutilized fish raw materials.
Place, publisher, year, edition, pages
Nature Research , 2024. Vol. 14, no 1, article id 1943
Keywords [en]
Animals, Erythrocytes, Fishes, Hemolysis, Hydrogen-Ion Concentration, Lipids, Muscles, Plasma, lipid, animal, erythrocyte, fish, muscle, pH
National Category
Health Sciences
Identifiers
URN: urn:nbn:se:ri:diva-71919DOI: 10.1038/s41598-024-52090-8Scopus ID: 2-s2.0-85182866645OAI: oai:DiVA.org:ri-71919DiVA, id: diva2:1841063
Funder
Swedish Research Council Formas, 2016-01181EU, Horizon 2020Region Västra Götaland, 837726, RUN 2019-00345
Note
This work was supported by the Swedish research council for sustainable development (FORMAS) Grant no. 2016-01181. This project has also received funding from Region Västra Götaland (project RUN 2019-00345) and the Bio Based Industries Joint Undertaking (JU) under grant agreement (No 837726). The JU receives support from the European Union’s Horizon 2020 research and innovation programme and the Bio Based Industries Consortium
2024-02-272024-02-272024-02-27Bibliographically approved